Similarly, SHH pathway inhibition in colorectal cancer (CRC) murine models leads to higher numbers of cells with tumour-initiating potential and accelerated tumour formation (Madison et al. 2005, Gerling et al. 2016). This evidence concerns the gene SHH and colorectal carcinoma.